Veracyte
VCYT · NASDAQ
Bulios Fair Price
$32.03
34.0% downside
Current Price
$48.54
According to Bulios Fair Price, VCYT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Veracyte, Inc. is an American biotechnology company specializing in diagnostics and predictive testing using advanced genomic technologies. The company develops and commercializes tests for the diagnosis and monitoring of various types of cancer and other diseases, such as lung cancer, thyroid cancer, and pulmonary fibrosis. Veracyte focuses on improving diagnostic accuracy and personalizing treatment for patients through non-invasive tests that assist healthcare providers in selecting the most appropriate therapeutic approach.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Marc Stapley
Employees
755
Headquarters
South San Francisco
Upcoming events
Earnings
Upcoming earnings report